Literature DB >> 12464381

Initial validation of a questionnaire for detecting gastroesophageal reflux disease in epidemiological settings.

Carlos Manterola1, Sergio Muñoz, Luis Grande, Luis Bustos.   

Abstract

There is a high prevalence of gastroesophageal reflux disease (GERD) in the general population. Prevalence studies are scarce, and there is a lack of valid instruments for measuring them. The aim of this paper is to validate a questionnaire for detecting GERD. A validity study design with pathologic GERD patients and controls was used. A sample of 240 subjects age and sex paired was selected in the ratio of 3:1 (patients to controls). The initial structured questionnaire contained a variety of GERD symptoms. Internal consistency, interobserver reliability, criteria validity using 24-h esophageal pH monitoring, construct validity, and extreme group validation were assessed. Sensitivity, specificity, and predictive values were also obtained in different cutoff points of the definitive scale. A total of 180 confirmed GERD patients and 60 controls were included in the study. Mean age in years was 45 +/- 13, with no statistical difference by gender (67% were female). Internal consistency of 0.75 and interobserver reliability of 0.87 was achieved in building the scale. Extreme group validation was highly significant by assessing the scale score with 24-h esophageal pH monitoring (P <.0001). At cutoff point 3 of the scale and with a correct classification of subjects of 92.4%, sensitivity, specificity, positive, and negative predictive values were 92, 95, 98, and 79%, respectively. The conclusion of this article is that a reliable and valid instrument was built to detect GERD.

Entities:  

Mesh:

Year:  2002        PMID: 12464381     DOI: 10.1016/s0895-4356(02)00454-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  17 in total

1.  Association between circulating levels of sex steroid hormones and Barrett's esophagus in men: a case-control analysis.

Authors:  Michael B Cook; Shannon N Wood; Brooks D Cash; Patrick Young; Ruben D Acosta; Roni T Falk; Ruth M Pfeiffer; Nan Hu; Hua Su; Lemin Wang; Chaoyu Wang; Barbara Gherman; Carol Giffen; Cathy Dykes; Veronique Turcotte; Patrick Caron; Chantal Guillemette; Sanford M Dawsey; Christian C Abnet; Paula L Hyland; Philip R Taylor
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-24       Impact factor: 11.382

2.  Validation of the nicotine dependence syndrome scale (NDSS): a criterion-group design contrasting chippers and regular smokers.

Authors:  Saul Shiffman; Michael A Sayette
Journal:  Drug Alcohol Depend       Date:  2005-02-12       Impact factor: 4.492

Review 3.  Questionnaire based gastroesophageal reflux disease (GERD) assessment scales.

Authors:  V Pratap Mouli; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2011-07-23

4.  Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data.

Authors:  Jennifer Drahos; Winnie Ricker; Ruth Parsons; Ruth M Pfeiffer; Joan L Warren; Michael B Cook
Journal:  J Clin Gastroenterol       Date:  2015-04       Impact factor: 3.062

5.  Interobserver agreement on signs and symptoms of patients with acute febrile illness.

Authors:  R P Daumas; P Brasil; C S Bressan; R V C Oliveira; B B G Carvalho; D V Carneiro; S R L Passos
Journal:  Infection       Date:  2011-04-13       Impact factor: 3.553

6.  Psychometric documentation of a quality-of-life questionnaire for patients undergoing antireflux surgery (QOLARS).

Authors:  Zs Zéman; S Rózsa; T Tihanyi; E Tarkó
Journal:  Surg Endosc       Date:  2004-12-09       Impact factor: 4.584

7.  A cross-sectional study of patterns of airway dysfunction, symptoms and morbidity in primary care asthma.

Authors:  Dominick Shaw; Ruth Green; Mike Berry; Sarah Mellor; Beverley Hargadon; Maria Shelley; Sue McKenna; Mike Thomas; Ian Pavord
Journal:  Prim Care Respir J       Date:  2012-09

8.  The Diagnostic Significance of Coapplying a Rabeprazole Test with the SF-36 for Gastroesophageal Reflux Disease.

Authors:  Ying Chen; Feng Wang; Yuanxi Jiang; Chen Wang; Liwen Yao; Ping Wu; Yili Tong; Huihui Sun; Shuchang Xu
Journal:  Gastroenterol Res Pract       Date:  2013-02-28       Impact factor: 2.260

9.  Comparison of gastroesophageal reflux disease symptoms and proton pump inhibitor response using gastroesophageal reflux disease impact scale questionnaire.

Authors:  So Young Jo; Nayoung Kim; Ji Hwan Lim; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Hyun Chae Jung
Journal:  J Neurogastroenterol Motil       Date:  2013-01-08       Impact factor: 4.924

10.  Applying data mining techniques in the development of a diagnostics questionnaire for GERD.

Authors:  Noya Horowitz; Menachem Moshkowitz; Zamir Halpern; Moshe Leshno
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.